Clinical applications of breast cancer metabolomics using high-resolution magic angle spinning proton magnetic resonance spectroscopy (HRMAS 1H MRS): systematic scoping review
- 21 Downloads
Breast cancer is a heterogeneous disease with different prognoses and responses to systemic treatment depending on its molecular characteristics, which makes it imperative to develop new biomarkers for an individualized diagnosis and personalized oncological treatment. Ex vivo high-resolution magic angle spinning proton magnetic resonance spectroscopy (HRMAS 1H MRS) is the most common technique for metabolic quantification in human surgical and biopsy tissue specimens.
To perform a review of the current available literature on the clinical applications of HRMAS 1H MRS metabolic analysis in tissue samples of breast cancer patients.
This systematic scoping review included original research papers published in the English language in peer-reviewed journals. Study selection was performed independently by two reviewers and preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines were followed.
The literature search returned 159 studies and 26 papers were included as part of this systematic review. There was considerable variation regarding tissue type, aims, and statistical analysis methods across the different studies. To facilitate the interpretation of the results, the included studies were grouped according to their aims or main outcomes into: feasibility and tumor diagnosis (n = 6); tumor heterogeneity (n = 2); correlation with proteomics/transcriptomics (n = 3); correlation with prognostic factors (n = 11); and response evaluation to NAC (n = 4).
There is a lot of potential in including metabolic information of breast cancer tissue obtained with HRMAS 1H MRS. To date, studies show that metabolic concentrations quantified by this technique can be related to the diagnosis, prognosis, and treatment response in breast cancer patients.
KeywordsBreast neoplasms Metabolomics Magnetic resonance spectroscopy
JG conducted the literature review and constructed the article database. AGVB and SBT performed the study selection and reviewed the selected studies. All authors were involved in writing the manuscript. All authors read and approved the manuscript.
This work was partially supported by the NIH/NCI Cancer Center Support Grant (P30 CA008748) and the Breast Cancer Research Foundation
Compliance with ethical standards
Conflicts of interest
Katja Pinker received payment for activities not related to the present article including lectures including service on speakers bureaus and for travel/accommodations/meeting expenses unrelated to activities listed from the European Society of Breast Imaging (MRI educational course, annual scientific meeting) and the IDKD 2019 (educational course).
This article does not contain any studies with human participants or animals performed by any of the authors.
- Bathen, T. F., Jensen, L. R., Sitter, B., Fjösne, H. E., Halgunset, J., Axelson, D. E., et al. (2007). MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Research and Treatment, 104(2), 181–189.PubMedCrossRefPubMedCentralGoogle Scholar
- Cao, M. D., Döpkens, M., Krishnamachary, B., Vesuna, F., Gadiya, M. M., Lønning, P. E., et al. (2012a). Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer. NMR in Biomedicine, 25(9), 1033–1042.PubMedPubMedCentralCrossRefGoogle Scholar
- Cao, M. D., Sitter, B., Bathen, T. F., Bofin, A., Lønning, P. E., Lundgren, S., et al. (2012c). Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling. NMR in Biomedicine, 25(2), 369–378.PubMedCrossRefPubMedCentralGoogle Scholar
- Chae, E. Y., Shin, H. J., Kim, S., Baek, H.-M., Yoon, D., Kim, S., et al. (2016). The role of high-resolution magic angle spinning 1H nuclear magnetic resonance spectroscopy for predicting the invasive component in patients with ductal carcinoma in situ diagnosed on preoperative biopsy. PLoS ONE, 11(8), e0161038.PubMedPubMedCentralCrossRefGoogle Scholar
- Choi, J. S., Baek, H.-M., Kim, S., Kim, M. J., Youk, J. H., Moon, H. J., et al. (2013). Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy. PLoS ONE, 8(12), e83866.PubMedPubMedCentralCrossRefGoogle Scholar
- Gogiashvili, M., Horsch, S., Marchan, R., Gianmoena, K., Cadenas, C., Tanner, B., et al. (2018). Impact of intratumoral heterogeneity of breast cancer tissue on quantitative metabolomics using high-resolution magic angle spinning 1H NMR spectroscopy. NMR in Biomedicine, 31(2), e3862.CrossRefGoogle Scholar
- Higgins, J. P. T., & Green, S. (2011). Cochrane handbook for systematic reviews of interventions. Version 5.1.0. London: The Cochrane Collaboration.Google Scholar
- Park, V. Y., Yoon, D., Koo, J. S., Kim, E.-K., Kim, S. Il, Choi, J. S., et al. (2016). Intratumoral agreement of high-resolution magic angle spinning magnetic resonance spectroscopic profiles in the metabolic characterization of breast cancer. Medicine, 95(15), e3398.PubMedPubMedCentralCrossRefGoogle Scholar
- Thakur, S. B., Horvat, J. V., Hancu, I., Sutton, O. M., Bernard-Davila, B., Weber, M., et al. (2019). Quantitative in vivo proton MR spectroscopic assessment of lipid metabolism: Value for breast cancer diagnosis and prognosis. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.26622.CrossRefPubMedPubMedCentralGoogle Scholar
- Yoon, H., Yoon, D., Yun, M., Choi, J. S., Park, V. Y., Kim, E. K., et al. (2016). Metabolomics of breast cancer using high-resolution magic angle spinning magnetic resonance spectroscopy: Correlations with 18F-FDG positron emission tomography-computed tomography, dynamic contrast-enhanced and diffusion-weighted imaging MRI. PLoS ONE, 11(7), e0159949.PubMedPubMedCentralCrossRefGoogle Scholar